Asian Liver Health Program | NYU Langone Health
New York City is home to over 1.1 million members of the Asian community. People of Asian descent are at increased risk for liver disease and have higher liver disease death rates than any other racial group.
US News & World Report’s “Best Hospitals” rank NYU Langone among the top 5 hospitals in the country for gastroenterology and gastrointestinal surgery.
That’s why NYU Langone’s Asian Liver Health Program is dedicated to providing advanced and specialized care for people with hepatitis B, hepatitis C, cirrhosis, liver cancer, and all other types of liver disease. Our team is sensitive and knowledgeable about the unique and diverse needs of the Asian community.
Advanced liver care
NYU Langone’s Asian Liver Health Program provides New York’s diverse Asian American community with the best care in the detection, diagnosis and treatment of liver disease, including liver transplantation. Our team of hepatologists (liver specialists), gastroenterologists, interventional radiologists, liver surgeons, medical oncologists, radiation oncologists and liver transplant experts work closely with our patients and their primary care physicians to ensure they receive the most advanced, integrated, and culturally appropriate treatment. care.
Our program also includes multilingual staff, interpreter services and educational materials in Asian languages.
The Asian Liver Health Program provides comprehensive care, including advanced medical care, interventional radiology procedures, and surgical options for people with liver disease.
For some patients with life-threatening liver disease, transplantation may offer the only hope for effective treatment and cure. Our team of highly trained and experienced hepatologists, surgeons, nurses and other specialists work together before, during and after the transplant procedure to ensure optimal results for our patients and their families.
Patient survival rates at our state-of-the-art facility, NYU Langone’s Transplant Institute, are consistently among the best in the country.
At NYU Langone, we lead pioneering activities clinical tests, ensuring that new experimental therapies are available for our patients with hepatitis, cirrhosis, liver cancer and other types of liver disease.